Regarding the relationship between Fibulin-3 and liver cancer, there are reports that Fibulin-3 inhibits the development of HCC49 and that patients with HCC with low Fibulin-3 expression have a poor prognosis.50 This evidence concerns the gene EFEMP1 and liver cancer.